Cervical Cancer Diagnostic Test Market - Global Industry Analysis

Cervical Cancer Diagnostic Test Market (Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) And Others) For Hospitals, Laboratories And Other End-Users - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends And Forecast, 2021 – 2028

Published Date: 14-May-2021 Category: Healthcare Report Format : PDF Pages: 130 Report Code: ZMR-164 Status : Published

The global cervical cancer diagnostic test market accounted for USD 7.45 Billion in 2020 and is expected to reach USD 15.45 Billion by 2028, expanding at a CAGR of 10.4% from 2021 to 2028.

Description

Cervical Cancer Diagnostic Test Market: Overview

The global cervical cancer diagnostic test market accounted for USD 7.45 Billion in 2020 and is expected to reach USD 15.45 Billion by 2028, expanding at a CAGR of 10.4% from 2021 to 2028.

Amongst the types of cancer identified as of now, cervical cancer is the one most prevalent amongst women. Research also states that 90% of the cases of cervical cancer could be attributed to HPV infection. The diagnosis happens through smear screening. The last few years have seen a substantial increase in the population of female smokers. Plus, the frequency of unsafe sex is increasing among teenagers. Therefore, the rate of cervical cancer is increasing in the young population.

To know more about this report, request a sample copy.

COVID-19 Impact Analysis:

The outbreak of COVID-19 has escalated the cervical cancer diagnostic tests, more so as the WHO has certified that those suffering from chronic diseases like cancer, and diabetes are more likely to contract Corona. These patients are trying to be doubly sure about the complexities, so that utmost care could be taken amidst the ongoing pandemic. The market for cervical cancer diagnostic tests is not expected to stand still by any means, looking at the situation on the whole.

Growth Factors:

The global cervical cancer diagnostic test market is significantly driven by the rise in the percentage of HPV in the female population. Lack of hygiene and non-awareness of cervical cancer in women is one of the significant factors to boost the need for cervical cancer diagnostic tests in women. According to CDC, more than seven million people acquire HPV in the U.S. Besides, changes in lifestyle, and availability of medical support are expected to propel the market growth. Genetic causes in women are also anticipated to contribute to the market growth in the coming years.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Test Segment Analysis Preview:

Based on the test, the global market of cervical cancer diagnostic test market is segmented as Pap smear tests, colposcopy, HPV testing, endocervical curettage (ECC), and others. The Pap smear tests accounted for a significant share registering a high CAGR in the past few years. In addition, it is expected to continue dominating in the coming years. Factors such as growing awareness and low test prices are likely to influence commercial growth. The HPV testing segment is anticipated to have a second leading share attributed to rising in incidences of HPV infections in the population.

End-User Segment Analysis Preview:

Based on end-user, the global market of cervical cancer diagnostics test market is trifurcated into hospitals, laboratories, and others. The hospital's segment was the leading segment in 2019. The segment is expected to continue its dominance during the forecast period.

To know more about this report, Request For Customization.

Regional Segment Analysis Preview:

North America held a significant share owing rise in awareness and presence of key players. Moreover, developed medical infrastructure offers lucrative opportunities for market development in the near future. The Asia Pacific is the second leading market for cervical cancer diagnostic tests owing to the large population with unmet medical needs. The rise in the geriatric population is one of the major reasons for growth within regional markets.

Key Players and Competitive Landscape:

Some of the key players in the cervical caner diagnostic test market include Abbott Laboratories, Becton, Dickinson and Company, Femasys Inc., Hologic Inc., Oncohealth Corp, Quest Diagnostics Inc, QIAGEN and Zilico Ltd.

The Global Cervical Cancer Diagnostic Test Market is segmented into:

By Test:

  • Pap Smear Tests
  • Colposcopy
  • HPV Testing
  • Endocervial Cutterage (ECC)
  • Others

By End-User:

  • Hospitals
  • Laboratories
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 : Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 : Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Test
        • 2.1.1.2. Market Attractiveness Analysis, By End-User
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Cervical Cancer Diagnostic Test Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 : COVID -19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 : Cervical Cancer Diagnostic Test Market – Test Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Test, 2020 & 2028
    • 4.2. Pap Smear Tests
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Culposcopy
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Endocervil Cutterage (ECC)
      • 4.4.1. Market Size and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2021 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Others
      • 4.5.1. Market Size and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 : Cervical Cancer Diagnostic Test Market – End-User Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By End-User, 2020 & 2028
    • 5.2. Hospitals
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Laboratories
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Others
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No.6 : Cervical Cancer Diagnostic Test Market – Regional Analysis
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Test, 2016 – 2028
      • 6.2.3. North America Market Revenue, By End-User, 2016 – 2028
      • 6.2.4. U.S.
        • 6.2.4.1. U.S. Market Revenue, By Test, 2016 – 2028
        • 6.2.4.2. U.S. Market Revenue, By End-User, 2016 – 2028
      • 6.2.5. Canada
        • 6.2.5.1. Canada Market Revenue, By Test, 2016 – 2028
        • 6.2.5.2. Canada Market Revenue, By End-User, 2016 – 2028
      • 6.2.6. Mexico
        • 6.2.6.1. Mexico Market Revenue, By Test, 2016 – 2028
        • 6.2.6.2. Mexico Market Revenue, By End-User, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Test, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By End-User, 2016 – 2028
      • 6.3.4. Germany
        • 6.3.4.1. Germany Market Revenue, By Test, 2016 – 2028
        • 6.3.4.2. Germany Market Revenue, By End-User, 2016 – 2028
      • 6.3.5. France
        • 6.3.5.1. France Market Revenue, By Test, 2016 – 2028
        • 6.3.5.2. France Market Revenue, By End-User, 2016 – 2028
      • 6.3.6. U.K.
        • 6.3.6.1. U.K. Market Revenue, By Test, 2016 – 2028
        • 6.3.6.2. U.K. Market Revenue, By End-User, 2016 – 2028
      • 6.3.7. Italy
        • 6.3.7.1. Italy Market Revenue, By Test, 2016 – 2028
        • 6.3.7.2. Italy Market Revenue, By End-User, 2016 – 2028
      • 6.3.8. Spain
        • 6.3.8.1. Spain Market Revenue, By Test, 2016 – 2028
        • 6.3.8.2. Spain Market Revenue, By End-User, 2016 – 2028
      • 6.3.9. Rest of Europe
        • 6.3.9.1. Rest of Europe Market Revenue, By Test, 2016 – 2028
        • 6.3.9.2. Rest of Europe Market Revenue, By End-User, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Test, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By End-User, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Test, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By End-User, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Test, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By End-User, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Test, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By End-User, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Test, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By End-User, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Test, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By End-User, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Test, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By End-User, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Test, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By End-User, 2016 – 2028
      • 6.5.4. Brazil
        • 6.5.4.1. Brazil Market Revenue, By Test, 2016 – 2028
        • 6.5.4.2. Brazil Market Revenue, By End-User, 2016 – 2028
      • 6.5.5. Argentina
        • 6.5.5.1. Argentina Market Revenue, By Test, 2016 – 2028
        • 6.5.5.2. Argentina Market Revenue, By End-User, 2016 – 2028
      • 6.5.6. Rest of Latin America
        • 6.5.6.1. Rest of Latin America Market Revenue, By Test, 2016 – 2028
        • 6.5.6.2. Rest of Latin America Market Revenue, By End-User, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Test, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By End-User, 2016 – 2028
      • 6.6.4. GCC Countries
        • 6.6.4.1. GCC Countries Market Revenue, By Test, 2016 – 2028
        • 6.6.4.2. GCC Countries Market Revenue, By End-User, 2016 – 2028
      • 6.6.5. South Africa
        • 6.6.5.1. South Africa Market Revenue, By Test, 2016 – 2028
        • 6.6.5.2. South Africa Market Revenue, By End-User, 2016 – 2028
      • 6.6.6. Rest of Middle-East Africa
        • 6.6.6.1. Rest of Middle-East Africa Market Revenue, By Test, 2016 – 2028
        • 6.6.6.2. Rest of Middle-East Africa Market Revenue, By End-User, 2016 – 2028
  • Chapter No. 7 : Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8 : Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Cervical Cancer Diagnostic Test Market: Company Market Share, 2019
      • 8.1.2. Global Cervical Cancer Diagnostic Test Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Cervical Cancer Diagnostic Test Market, Company Y-o-Y Growth, 2016 – 2019 (%)
      • 8.1.4. Global Cervical Cancer Diagnostic Test Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9 : Company Profiles
    • 9.1. Abbott Laboratories
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Becton Dickinson and Company
    • 9.3. Femasys Inc
    • 9.4. Hulogic Inc
    • 9.5. Oncohealth Corp
    • 9.6. Quest Diagnostics Inc
    • 9.7. QIAGEN
    • 9.8. Zilico Ltd
  • Chapter No. 10 : Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11 : Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Test
FIG NO. 2. Market Attractiveness Analysis, By End-User
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Cervical Cancer Diagnostic Test Market Revenue, 2016 – 2028 (USD  Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Test , 2020 & 2028
FIG NO. 7. Global Cervical Cancer Diagnostic Test Market for Pap Smear Tests, Revenue  (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Cervical Cancer Diagnostic Test Market for  Pap Smear Tests, By Country, 2020 & 2028
FIG NO. 9. Global Cervical Cancer Diagnostic Test Market for Colposcopy, Revenue  (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Cervical Cancer Diagnostic Test Market for  Colposcopy, By Country, 2020 & 2028
FIG NO. 11. Global Cervical Cancer Diagnostic Test Market for Endocervil Cutterage (ECC),  Revenue  (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Cervical Cancer Diagnostic Test Market for  Endocervil Cutterage (ECC),  By Country, 2020 & 2028
FIG NO. 13. Global Cervical Cancer Diagnostic Test Market for Others, Revenue (USD  Billion) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Cervical Cancer Diagnostic Test Market for  Others, By Country, 2020 & 2028
FIG NO. 15. Market Revenue Share, By End-User, 2020 & 2028
FIG NO. 16. Global Cervical Cancer Diagnostic Test Market for Hospitals, Revenue (USD  Billion) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Cervical Cancer Diagnostic Test Market for  Hospitals, By Country, 2020 & 2028
FIG NO. 18. Global Cervical Cancer Diagnostic Test Market for Laboratories,  Revenue(USD Billion) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Cervical Cancer Diagnostic Test Market for  Laboratories, By Country, 2020 & 2028
FIG NO. 20. Global Cervical Cancer Diagnostic Test Market for Others, Revenue (USD  Billion)  2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Cervical Cancer Diagnostic Test Market for  Others, By Country, 2020 & 2028 
FIG NO. 22. Global Cervical Cancer Diagnostic Test Market Revenue Share, By Region,  2020 & 2028
FIG NO. 23. North America Cervical Cancer Diagnostic Test Market Revenue, 2016 –  2028 (USD Billion)
FIG NO. 24. Porter’s Five Forces Analysis for Global Cervical Cancer Diagnostic Test  Market
FIG NO. 25. PEST Analysis for Global Cervical Cancer Diagnostic Test Market
FIG NO. 26. Pricing Analysis for Global Cervical Cancer Diagnostic Test Market
FIG NO. 27. Value Chain Analysis for Global Cervical Cancer Diagnostic Test Market
FIG NO. 28. Company Share Analysis, 2019
FIG NO. 29. Radar Determinant Chart, 2019
FIG NO. 30. Company Strategic Developments – Heat Map Analysis
FIG NO. 31. Hologic Inc., Business Segment Revenue Share, 2020 (%)
FIG NO. 32. Hologic Inc., Geographical Segment Revenue Share, 2020 (%)
FIG NO. 33. Market Channels
FIG NO. 34. Marketing Channel Development Trend
FIG NO. 35. Growth in World Gross Test, 2008-2018
FIG NO. 36. Research Methodology – Detailed View
FIG NO. 37. Research Methodology
 


Table Of Tables

List of Tables 

TABLE NO. 1. : Global Cervical Cancer Diagnostic Test Market: Snapshot
TABLE NO. 2. : Quarterly Cervical Cancer Diagnostic Test Market Revenue by Region, 2020
TABLE NO. 3. : Quarterly Cervical Cancer Diagnostic Test Market Revenue Forecast by  Region,  2021
TABLE NO. 4. : Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
TABLE NO. 5. : Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
TABLE NO. 6. : Global Cervical Cancer Diagnostic Test Market for Pap Smear Tests, by  Region,  2016 – 2028 (USD Billion)
TABLE NO. 7. : Global Cervical Cancer Diagnostic Test Market for Colposcopy, by  Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. : Global Cervical Cancer Diagnostic Test Market for Endocervil Cutterage (ECC),  by Region, 2016– 2028 (USD Billion)
TABLE NO. 9. : Global Cervical Cancer Diagnostic Test Market for Others, by Region, 2016 –  2028 (USD  Billion)
TABLE NO. 10. Global Cervical Cancer Diagnostic Test Market for Hospitals, by Region, 2016  – 2028 (USD Billion)
TABLE NO. 11. : Global Cervical Cancer Diagnostic Test Market for Laboratories, by  Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. : Global Cervical Cancer Diagnostic Test Market for Others, by Region,  2016 – 2028 (USD Billion)
TABLE NO. 13. : Global Cervical Cancer Diagnostic Test Market Revenue, By Region, 2016 –  2028 (USD Billion)
TABLE NO. 14. : North America Cervical Cancer Diagnostic Test Market Revenue, By Country,  2016 – 2028 (USD Billion)
TABLE NO. 15. : North America Cervical Cancer Diagnostic Test Market Revenue, By  Test,  2016 – 2028 (USD Billion)
TABLE NO. 16. : North America Cervical Cancer Diagnostic Test Market Revenue, By End-User,  2016 – 2028 (USD Billion)
TABLE NO.17. : U.S. Cervical Cancer Diagnostic Test Market Revenue, By Test, 2016 –2028  (USD Billion)
TABLE NO. 18. : Canada Cervical Cancer Diagnostic Test Market Revenue, By  Test, 2016 –  2028(USD Billion)
TABLE NO. 19. : Canada Cervical Cancer Diagnostic Test Market Revenue, By End-User, 2016  – 2028 (USD Billion)
TABLE NO. 20. : Mexico Cervical Cancer Diagnostic Test Market Revenue, By Test, 2016 –  2028(USD Billion)
TABLE NO. 21. : Mexico Cervical Cancer Diagnostic Test Market Revenue, By End-User, 2016  – 2028 (USD Billion)
TABLE NO. 22. : Drivers for the Cervical Cancer Diagnostic Test Market: Impact Analysis
TABLE NO. 23. : Restraints for the Cervical Cancer Diagnostic Test Market: Impact Analysis
TABLE NO. 24. : Major Buyers of Cervical Cancer Diagnostic Test
TABLE NO. 25. : Distributors/Traders List of Cervical Cancer Diagnostic Test
TABLE NO. 26. : Global Cervical Cancer Diagnostic Test Market, Company Market Revenue,  2016 – 2019 (USD Billion)
TABLE NO. 28. : Global Cervical Cancer Diagnostic Test Market, Company Y-o-Y Growth, 2016   – 2019 (USD Billion)

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Cervical Cancer Diagnostic Test market. Zion Research has collected and analyzed key data belong to the global Cervical Cancer Diagnostic Test market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Cervical Cancer Diagnostic Test across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Cervical Cancer Diagnostic Test industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Cervical Cancer Diagnostic Test market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Cancer is defined as abnormal growth of cells with the potential to spread to other parts of the body. There are various types of cancer affecting different parts of the body. Cancer which develops in the cervix is called as cervical cancer. Two major types of cervical cancers diagnosed in women include adenocarcinoma and squamous cell carcinoma. Almost all types of cervical cancer are caused by human papiloma virus (HPV). Cervical cancer is the third most common cancer among women and the second most frequent cause of cancer-related death, accounting for almost 3,00,000 deaths annually. Diagnosis of cervical cancer is done by pap smear tests, colposcopy, HPV testing, endocervical curettage (ECC). Cervical cancer is a sexually transmitted disease that can be prevented by early detection and vaccination.

Globally, cervical cancer diagnostic test market has been accelerated by increasing the percentage of HPV infected female population across the globe. According to the Center for Disease Control and Prevention (CDC), six million people in the U.S. acquire HPV each year.  At least 20 million already suffer from cervical cancer, and more than half of all sexually-active adults will be infected during their lifetime. Furthermore increasing the incidence of weakened immune system coupled with certain life history is also considered as a major governing factor which promotes the cause of cervical cancer in female and thus promotes the cervical cancer diagnostic market. Moreover many lifestyle-related factors, such as having multiple sex partners, smoking, obesity, unsafe sex and inherited HPV-positive patient, are estimated to drive the cervical diagnostics market. However, lack of education regarding the prevalence of cervical cancer and the unwillingness of the female population to undergo cervical cancer prognosis would hinder the growth of the market. In addition, HPV vaccination which makes people hesitant for conducting cervical cancer diagnostic test is also one of the restraining factors in a growth of cervical cancer diagnostic market.

Cervical Cancer Diagnostic Test

Based on the test, the global market of cervical cancer diagnostic test is bifurcated into five types: Pap smear tests, colposcopy, HPV testing, endocervical curettage (ECC) and others (Cone Biopsy and Loop Electrosurgical Excision Procedure). The Pap smear tests segment accounted for the largest share of approximately more than 50% of the total cervical cancer diagnostic tests market in 2015. Factors attributed to the dominance of Pap smear tests are lower test prices and growing awareness about cancer diagnosis and benefits of early detection. Similarly, the HPV testing is forecast to grow at the fastest growth rate of approximately more than 9% from 2015 to 2021 of the cervical cancer diagnostic tests market. The rapid growth of the HPV testing segment is attributed due to the increasing incidence of HPV infections and risk of abnormal Pap test.

Based on end-user, the global market of cervical cancer diagnostics/test is bifurcated into three types: hospitals, laboratories, and others. The hospital's segment was the leading segment in 2015. The segment is expected to continue its dominance during the forecast period.

Based on geographies, the global market of cervical cancer diagnostics/test is bifurcated into five regions: North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. These segments are further bifurcated into the U.S., UK, Germany, France, China, Japan, India, and Brazil. North America accounted for the largest share of the global cervical cancer diagnostics/test market, followed by Europe. This growth is attributed due to rising awareness related to health care in this region. Moreover, cervical cancer diagnostics/test market has the huge opportunity in the emerging markets of Asia Pacific due to increasing standard of living, large patient base in this region. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, due to the rising incidence of cervical cancer, increasing government support, and growing upper middle-class population and rise in disposable income levels in this region.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global cervical cancer diagnostic test market include Abbott Laboratories, Becton, Dickinson and Company, Femasys, Inc., Hologic, Inc., Guided Therapeutics, Inc., OncoHealth Corp., Quest Diagnostics, Inc., Roche Diagnostics, QIAGEN, and Zilico Ltd.

Choose License Type

FrequentlyAsked Questions

The global cervical cancer diagnostic test  market was valued at USD 7.45 Billion in 2020.

The global cervical cancer diagnostic test market is expected to reach USD 15.45 Billion by 2028, expanding at a CAGR of 10.4% between 2021 to 2028.

Some of the key factors driving the global cervical cancer diagnostic test market growth comprise the lack of hygiene and non-awareness of cervical cancer in women is one of the significant factor to boost the need for cervical cancer diagnostic tests in women.

North America held a substantial share of the cervical cancer diagnostic test market in 2020 owing to the rise in awareness and the presence of top companies. China is world’s largest manufacturer of healthcare devices and advanced technology.

Some of the major companies operating in global cervical cancer diagnostic test market are Abbott Laboratories, Becton, Dickinson and Company, Femasys Inc., Hologic Inc., Oncohealth Corp, Quest Diagnostics Inc, QIAGEN and Zilico Ltd.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed